About VCGS Pathology

The Victorian Clinical Genetics Services (VCGS) is a wholly owned subsidiary of the Murdoch Childrens Research Institute (MCRI). VCGS Pathology are the laboratories of the VCGS which provide screening and diagnostic laboratory services to the people of Victoria, Tasmania and other sites that choose to use our services.

Our scientists have expertise in cytogenetics, molecular genetics, biochemical genetics, mitochondrial genetics and tissue culture. They provide a first rate diagnostic service in fully accredited laboratories and many are involved in research and development activities.

Our scientists work in close collaboration with the geneticists and genetic counsellors of Genetic Health Services Victoria (GHSV), the clinicians of the VCGS, as well as the research scientists in the Murdoch Childrens Research Institute. The diagnostic laboratories of VCGS Pathology are located on the 9th and 10th floors of The Royal Children's Hospital.

Quality Assurance

All seven VCGS Pathology laboratories achieved renewed NATA accreditation in 2004 to the standard ISO/IEC 17025. Ms Anne Robertson is the designated Laboratory Quality Assurance Officer.

Vision

To be an internationally recognised centre of excellence in clinical and laboratory genetics

Mission

To provide accessible clinical and laboratory genetic services of the highest standard to the people of Victoria, and to others outside the State who seek our services, with a commitment to excellence in research and education.

Goals

(these being the means through which the mission is achieved):

• To work with our strategic partners to provide excellent clinical and laboratory diagnosis and counselling services to people of all ages
• To support the rights of our clients and patients to make informed choices in their own health care
• To act in advocacy for our clients and patients
• To provide a supportive environment for our staff, and to encourage their professional development
• To be leaders in genetic education and training
• To actively participate in translational research and development of new tests, technologies and genetic knowledge for the benefit of our clients and patients
• To keep our operations well administered, and on a sound financial footing